New York, NY, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB:  TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced the inclusion of the phrase “DRUG TEST SAFE” on the Back-Side graphic design (“Back-Side”) of each individual pack of Tauri-Gum TM .  The phrase will appear on the lower right section (in green font), above the Company’s logo (directly to the right of the GS1 barcode).  The Company believes that this clarification is of significant importance, as this product has been formulated with 0% THC content.  As recently disclosed, the Company has implemented quality assurance protocols (“QA protocols”) within the manufacturing process to ensure that this above-referenced standard is strictly adhered to. 

Each production batch of the Company’s CBD Infused gum, will be independently tested by a 3 rd  party laboratory.  In addition, the Company has opted to package its product in a tamper resistant “blister pack” format.  The Company has also included the following instructions on the Back-Side of each Tauri-Gum TM pack: “Use only if the foil seal [blister pack] is intact.”

The Company is targeting the month of March 2019 for its commercial launch of Tauri-Gum TM and is hopeful to generate revenue during this current operating quarter (its 4 th  Fiscal Quarter of 2019).

ABOUT: TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. ( TAUG ) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum TM .  See also  our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at  www.tauriga.com .

In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum.  This site is being constructed under the following URL address:   www.taurigum.com

Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Attachment

Contact: CONTACT INFORMATION Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY  10022 Chief Executive Officer Mr. Seth M. Shaw Email:  sshaw@tauriga.com cell # (917) 796 9926 www.tauriga.com